New Delhi, Jan 16 (NationPress) The Council of Scientific and Industrial Research (CSIR) is making strides to reshape India’s scientific landscape by innovating road construction through eco-friendly technology, safeguarding biodiversity, and enhancing healthcare with locally developed diagnostic kits, as reported.

Since 2015, CSIR laboratories nationwide have significantly contributed to advancements that bolster infrastructure, improve health outcomes, enhance climate resilience, and strengthen India's strategic independence, as highlighted by the Times of Oman.

According to the report, “The year 2025 will be recognized as a pivotal moment in India’s scientific evolution, marking a shift where research directly supports national development.”

Under CSIR's initiative, green technology has been successfully implemented to upgrade over 200 kilometers of rural roads in Uttar Pradesh.

This innovation has decreased emissions and facilitated quicker and more resilient construction.

The world's first port road at Hazira, Gujarat, was constructed using steel slag technology, converting industrial waste into a sustainable and durable asset by CSIR-Central Road Research Institute (CRRI).

Moreover, approximately 30 tonnes of end-of-life plastic technical textiles were incorporated into expressway construction.

In agriculture, CSIR-National Botanical Research Institute (NBRI) developed the world’s first genetically modified cotton that is fully resistant to the pink bollworm, a pest causing significant crop failures.

Additionally, CSIR-Centre for Cellular and Molecular Biology (CCMB) has played a crucial role in biodiversity preservation by creating the world’s first DNA-based test designed to identify illegal shahtoosh in pashmina shawls, aiding in the protection of the endangered Tibetan antelope.

The lab also launched India’s inaugural Zoo Bio Bank at Darjeeling Zoo, aimed at preserving the genetic material of endangered species for future conservation efforts and research.

CSIR laboratories have also revolutionized healthcare through indigenous scientific advancements.

For instance, CSIR-CCMB developed a rapid, cost-effective molecular test for sickle cell anemia, allowing for early diagnosis using just a single drop of dried blood, while the CSIR-Institute of Genomics and Integrative Biology (IGIB) pioneered India’s first indigenous CRISPR-based gene therapy for sickle cell disease.

Furthermore, CSIR-Indian Institute of Chemical Biology and collaborating laboratories have progressed in creating innovative therapies for triple-negative breast cancer, including advanced anti-cancer agents and targeted nanoparticle drug delivery systems.

CSIR’s initiatives have also contributed to constructing climate-resilient homes and smarter waste management systems. The laboratories have fortified defense capabilities and fostered innovation through industry partnerships and startups.